Tuesday, March 31, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

A conversation with Dr. Cifu, author of Ending Medical Reversal

We discuss Dr. Cifu’s book, Ending Medical Reversal, which discusses why we enact healthcare policies based on weak evidence or outright erroneous beliefs. We delve into policy reversals discussed in the book and those seen during the pandemic.

To purchase his book, co-authored with Dr. Vinay Prasad, please select the link below:

https://jhupbooks.press.jhu.edu/title/ending-medical-reversal

We also encourage you to read his article discussing the recent Aspirin policy reversal coming from the USPSTF:

https://www.medpagetoday.com/opinion/vinay-prasad/95281

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!